The Lancet publishes studies showing Roche’s faricimab improved and maintained vision in two leading causes of vision loss, extending time between treatments up to four months

Two papers in The Lancet highlight one-year results from Roche’s phase III trials evaluating faricimab in neovascular or “wet” age-related macular (nAMD) and diabetic macular edema (DME) Across four studies, about half of eligible faricimab patients were able to go four months between treatments, and approximately three-quarters could be treated every three months or longer... Read more

Xylem Clocks 113,000 Volunteer Hours in 2021, Doubling Time Donated to Help Tackle Water Challenges in 55 Countries

RYE BROOK, N.Y.–(BUSINESS WIRE)–Jan. 20, 2022– Global water technology company, Xylem (NYSE:XYL), announced today that almost 80 percent of its 16,000 employees volunteered their time to help solve urgent water challenges in 2021. Xylem’s global team collectively donated 113,000 hours in their communities, across 55 countries. The commitment of volunteer hours doubled from 2020 to... Read more

Looking for One in Many Millions

Circulating tumor cells (CTCs) are cells that have broken away from a primary tumor and entered the circulatory system. They can initiate new tumors (metastases) that are the driving factor for the vast majority of cancer-related deaths. Biopharma researchers, cancer researchers and oncologists have focused on the detection and analyses of CTCs to monitor drug... Read more

MKS Withdraws from Photonics West 2022

ANDOVER, Mass., Jan. 10, 2022 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI) (“MKS”), a global provider of technologies that enable advanced processes and improve productivity, today announced that it has withdrawn from exhibiting at Photonics West 2022 in San Francisco. Read more

Using Zebrafish to Understand How Blood and Lymphatic Vessels Develop

The above image displaying ribosomal biogenesis and blood vessels in developing zebrafish embryos was awarded first prize in the life sciences category of the LMA/VIA 2021 Image Competition (sponsored by ZEISS) of the Australian Microscopy & Microanalysis Society. Dr. Kazuhide Shaun Okuda, Postdoctoral Fellow at the Hogan laboratory, Peter MacCallum Cancer Centre in Victoria, Australia, took... Read more

PacBio to Present at Upcoming Investor Conference

MENLO PARK, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) — PacBio announced today that its executives will be speaking virtually at the following investor conference: 40th Annual J.P. Morgan Healthcare Conference on January 13, 2022, at 12:00 pm Eastern Time (9:00 am Pacific Time) The live webcast can be accessed at the company’s investors page at... Read more